Drug factory · FDA FEI 3007027193

Par Formulations Private Limited

9/215, Pudupakkam-Vandalur Main Road, Pudupakkam, Kelambakkam, , , Chennai, India

India: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 10, 2026.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

7 drug inspections on record since 2011: 5 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
AllopurinolMakes it, tests it and packages it ENDO USA, Inc. 0603-2115, 0603-2116
DantroleneMakes it, tests it and packages it Par Health USA, LLC 42023-124, 42023-125, 42023-126 +3
GabapentinMakes it Allied Pharma Inc 76267-150, 76267-151
MethylprednisoloneMakes it, tests it and packages it Par Health USA, LLC 0603-4593
PerphenazineMakes it, tests it and packages it Par Health USA, LLC 0603-5060, 0603-5061, 0603-5062 +1
PrednisoneMakes it, tests it and packages it Par Health USA, LLC 0603-5335, 0603-5336, 0603-5337 +2
SapropterinMakes it, tests it and packages it ENDO USA, Inc. 49884-720

FDA inspection history

EndedResultProgramProblems noted
Jun 10, 2026Problems found, fixed voluntarilyDrug Quality Assurance—
Mar 24, 2023No problems foundDrug Quality Assurance—
Jun 21, 2019No problems foundDrug Quality Assurance—
Dec 7, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 17, 2015No problems foundDrug Quality Assurance—
Oct 17, 2013No problems foundDrug Quality Assurance—
Sep 21, 2011No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; manufacture; pack.